NOVEL USE OF AIMP1 FOR CONTROLLING GLUCOSE LEVEL

摘要

The present invention relates to a novel use of AIMPl for controlling glucose level. More particularly, the present invention relates to a method for controlling glucose level in a subject, and a method for preventing or treating hypoglycemia or disease associated with hypoglycemia in a subject, which comprise administering to a subject in need thereof an effective amount of AIMPl, its functional equivalent or a nucleic acid encoding them. Also, the present invention relates to a composition for controlling glucose level in a subject, and a composition for preventing and treating hypoglycemia or disease associated with hypoglycemia in a subject, which comprises AIMPl, its functional equivalent or a nucleic acid encoding them as an effective ingredient.